Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Plos One|October 28, 2014
Protective effect of different anti-rabies virus VHH constructs against rabies disease in miceSanne Terryn, Aurélie Francart, Sophie Lamoral, et al.
The Journal of Infectious Diseases|November 4, 2006
Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrheaNeha Pant, Anna Hultberg, Yaofeng Zhao, et al.
The Journal of Biological Chemistry|April 30, 2016
Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) AntibodiesChristophe Blanchetot, Natalie De Jonge, Aline Desmyter, et al.
Scientific Reports|August 23, 2016
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacyMarie Godar, Virginia Morello, Ava Sadi, et al.
Mabs|May 29, 2015
Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platformAlex Klarenbeek, Khalil El Mazouari, Aline Desmyter, et al.
Nature Biotechnology|June 29, 2002
In situ delivery of passive immunity by lactobacilli producing single-chain antibodiesCarina Krüger, Yanzhong Hu, Qiang Pan, et al.
The Journal of Clinical Investigation|May 29, 2014
Four individually druggable MET hotspots mediate HGF-driven tumor progressionCristina Basilico, Anna Hultberg, Christophe Blanchetot, et al.
Protein Engineering, Design & Selection : PEDS|March 7, 2016
Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeuticsAlex Klarenbeek, Christophe Blanchetot, Georg Schragel, et al.
Plos One|April 13, 2011
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral moleculesAnna Hultberg, Nigel J Temperton, Valérie Rosseels, et al.
Haematologica|February 13, 2023
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapyThomas Pabst, Norbert Vey, Lionel Adès, et al.
Pageof 3